vs
Side-by-side financial comparison of Envoy Medical, Inc. (COCH) and SMITH & NEPHEW PLC (SNN). Click either name above to swap in a different company.
Envoy Medical, Inc. is a medical technology firm specializing in developing and commercializing advanced implantable hearing solutions for sensorineural hearing loss patients. Its core products include fully implanted middle ear hearing devices, with primary markets across North America and Europe, serving users who gain limited benefit from conventional external hearing aids.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.0K | — | ||
| Q3 25 | $42.0K | — | ||
| Q2 25 | $78.0K | — | ||
| Q1 25 | $46.0K | — | ||
| Q4 24 | $42.0K | — | ||
| Q3 24 | $56.0K | — | ||
| Q2 24 | $68.0K | — | ||
| Q1 24 | $59.0K | — |
| Q4 25 | $-6.6M | — | ||
| Q3 25 | $-6.5M | — | ||
| Q2 25 | $-5.7M | — | ||
| Q1 25 | $-5.0M | — | ||
| Q4 24 | $-4.6M | — | ||
| Q3 24 | $-6.0M | — | ||
| Q2 24 | $-3.9M | — | ||
| Q1 24 | $-6.3M | — |
| Q4 25 | -181.3% | — | ||
| Q3 25 | -383.3% | — | ||
| Q2 25 | -200.0% | — | ||
| Q1 25 | -391.3% | — | ||
| Q4 24 | -273.8% | — | ||
| Q3 24 | -233.9% | — | ||
| Q2 24 | -260.3% | — | ||
| Q1 24 | -159.3% | — |
| Q4 25 | -8513.3% | — | ||
| Q3 25 | -13590.5% | — | ||
| Q2 25 | -6500.0% | — | ||
| Q1 25 | -11102.2% | — | ||
| Q4 24 | -10828.6% | — | ||
| Q3 24 | -8878.6% | — | ||
| Q2 24 | -7135.3% | — | ||
| Q1 24 | -8278.0% | — |
| Q4 25 | -8781.3% | — | ||
| Q3 25 | -15433.3% | — | ||
| Q2 25 | -7294.9% | — | ||
| Q1 25 | -10865.2% | — | ||
| Q4 24 | -10995.2% | — | ||
| Q3 24 | -10642.9% | — | ||
| Q2 24 | -5804.4% | — | ||
| Q1 24 | -10627.1% | — |
| Q4 25 | $-0.27 | — | ||
| Q3 25 | $-0.35 | — | ||
| Q2 25 | $-0.32 | — | ||
| Q1 25 | $-0.29 | — | ||
| Q4 24 | $-0.40 | — | ||
| Q3 24 | $-0.39 | — | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.41 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
